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ABSTRACT 
Background: Numerous local studies have shown that there were poor adherence to 
T2DM clinical practice guideline (CPG) recommendations among primary care 
providers (PCP) and poor medication adherence among T2DM patients in primary care. 
The Chronic Care Model (CCM) had been proven to be effective in improving 
providers' adherence to CPG and medication adherence among T2DM patients in 
developed countries. However, evidence in developing countries is still lacking. 
Objectives: The first objective of this study was to design a pragmatic intervention 
based on the CCM i.e. EMPOWER-PAR intervention. The second objective was to 
evaluate the effectiveness of this intervention in improving the PCPs' adherence to 
T2DM CPG, medication adherence level and clinical outcomes among T2DM patients 
in the Malaysian public primary care setting. Methods: This is a sub study of a larger 
pragmatic cluster randomized controlled trial - participatory action research which was 
conducted in 10 public primary care clinics in Selangor and Kuala Lumpur. Five clinics 
were randomly selected to provide the EMPOWER-PAR intervention for 1 year and 
another 5 clinics continued with usual care. The PCPs' adherence to T2DM CPG was 
measured using the 'Process of Care Questionnaire', which includes the indicators of 
care as recommended by the Malaysian CPG on the Management of T2DM. Data were 
collected from the patients' medical records, retrospectively at baseline and at 1-year 
follow-up. Medication adherence levels among T2DM patients were measured using 
the previously validated Malay version of the Morisky Medication Adherence Scale -
8 (MMAS-8). Data were collected using face-to-face interview by trained interviewers, 
at baseline and at 1-year follow-up. Clinical outcome data were collected at baseline 
and at 1-year follow-up. Intention to treat analysis was performed for all outcome 
measures. A generalised estimating equation method was used to account for the 
baseline differences and the clustering effect. Results: A total of 888 patients were 
recruited at baseline; 471 were in the intervention and 417 in the control group. There 
was no significant demographic difference between the two groups at baseline except 
for ethnicity. At 1-year, 455 (96.6%) and 406 (97.3%) patients in the intervention and 
control groups completed the study, respectively. There were significant improvements 
in the percent change of the level of PCPs' adherence in the intervention compared to 
the control group at 1-year follow-up in several indicators of care. The intervention 
improved medication adherence levels twice more likely compared to usual care 
(adjusted OR 2.18, 95% CI 1.55 - 3.06, p-value<0.001). The proportion of patients 
achieving HbAlc target in the intervention group was significantly higher compared to 
the control groups (18.0% vs. 12.5%, p-value=0.022). The intervention also improved 
the proportion of T2DM patients achieving HbAlc target twice more likely compared 
to usual care (adjusted OR 2.34, 95% CI 1.22 - 4.51, p-value<0.011). Conclusions: 
The EMPOWER-PAR intervention has been proven to be effective in improving the 
PCPs' adherence to T2DM CPG in several indicators of care, patients' medication 
adherence levels and the proportion of patients achieving HbAlc target. Findings from 
this study provided objective evidence of the effectiveness of this intervention in the 
Malaysian public primary care setting. 
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